Robert Knight
Impact in
- Hematology top 0.05%
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
- Oncology top 0.5%
- Bone health and treatments
Papers in
- Hematology 96
- Multiple Myeloma Research and Treatments 67
- Acute Myeloid Leukemia Research 25
- Oncology 17
- Bone health and treatments 11
- Cutaneous Melanoma Detection and Management 3
- Co-authors
- Jerome B. Zeldis (48 shared papers)Zhinuan Yu (23 shared papers)Marta Olesnyckyj (28 shared papers)Meletios Athanasios Dimopoulos (23 shared papers)John J. Seaman (11 shared papers)Dirk J. Reitsma (6 shared papers)Joseph F. Simeone (5 shared papers)John R. Patin (4 shared papers)
- Journals
- Blood (69 papers)Journal of Clinical Oncology (13 papers)New England Journal of Medicine (7 papers)Development (5 papers)Cancer (4 papers)
- Partner nations
- United StatesUnited KingdomGreece
In The Last Decade
Robert Knight
166 papers receiving 16.9k citations
Robert Knight's Hit Papers
Peers
Comparison fields: 5 of 99
- Hematology 10.3k
- Oncology 2.5k
- Internal Medicine 181
- Genetics 392
- Cancer Research 200
Countries citing papers authored by Robert Knight
This map shows the geographic impact of Robert Knight's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Knight with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Knight more than expected).
Fields of papers citing papers by Robert Knight
This network shows the impact of papers produced by Robert Knight. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Knight. The network helps show where Robert Knight may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Knight, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 167 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia Hit paper breakdown → | 2017 | 1224 |
| 2 | Lenalidomide plus Dexamethasone for Relapsed or Refractory Multiple Myeloma Hit paper breakdown → | 2007 | 1223 |
| 3 | Lenalidomide in the Myelodysplastic Syndrome with Chromosome 5q Deletion Hit paper breakdown → | 2006 | 1078 |
| 4 | Lenalidomide plus Dexamethasone for Relapsed Multiple Myeloma in North America Hit paper breakdown → | 2007 | 1059 |
| 5 | Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma Hit paper breakdown → | 1996 | 870 |
| 6 | Efficacy of Pamidronate in Reducing Skeletal Complications in Patients with Breast Cancer and Lytic Bone Metastases Hit paper breakdown → | 1996 | 849 |
| 7 | Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma Hit paper breakdown → | 2010 | 728 |
| 8 | Efficacy of Lenalidomide in Myelodysplastic Syndromes Hit paper breakdown → | 2005 | 727 |
| 9 | Lenalidomide and Dexamethasone in Transplant-Ineligible Patients with Myeloma Hit paper breakdown → | 2014 | 686 |
| 10 | Lenalidomide Maintenance After Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: A Meta-Analysis Hit paper breakdown → | 2017 | 532 |
| 11 | 1998 | 528 | |
| 12 | 1999 | 502 | |
| 13 | 1998 | 498 | |
| 14 | 2006 | 428 | |
| 15 | 2011 | 412 | |
| 16 | 2007 | 358 | |
| 17 | 2009 | 315 | |
| 18 | 2008 | 280 | |
| 19 | 2004 | 259 | |
| 20 | 2007 | 247 |
About Robert Knight
Robert Knight is a scholar working on Hematology, Oncology, Genetics, Molecular Biology and Pathology and Forensic Medicine, having authored 167 papers that have together received 17.6k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (67 papers), Acute Myeloid Leukemia Research (25 papers), Bone health and treatments (11 papers), Developmental Biology and Gene Regulation (9 papers), Lymphoma Diagnosis and Treatment (4 papers), Cutaneous Melanoma Detection and Management (3 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Muscle Physiology and Disorders (3 papers). The work is most often cited by research in Hematology (10.3k citations), Oncology (2.5k citations), Internal Medicine (181 citations), Genetics (392 citations) and Cancer Research (200 citations). Robert Knight has collaborated with scholars based in United States, United Kingdom and Greece. Frequent co-authors include Jerome B. Zeldis, Zhinuan Yu, Marta Olesnyckyj, Meletios Athanasios Dimopoulos, John J. Seaman, Dirk J. Reitsma, Joseph F. Simeone, John R. Patin, Allan Lipton and Alan F. List. Their work appears in journals such as Blood, Journal of Clinical Oncology, New England Journal of Medicine, Development and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.